Your Source for BioScience Venture Capital Data
  • SEARCH THE OnBioVC DATABASE:

  • OnBioVC NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon
  • Photobucket

  • FDA Registered Contract Manufacturer

Phreesia (New York, NY) commercial-stage device product automating patient check-in and wireless interface with physicians’ existing and future technology, closed a $11.6M Series C financing. Participants include BlueCross BlueShield Venture Partners, Polaris Venture Partners, HLM Venture Partners and Long River Ventures.

Vivaldi Biosciences (New York, NY) an early-stage developer of vaccines for the prevention of seasonal influenza and emergent pandemic flu closed a $18.9M Series A financing Participants include Bay City Capital, NGN Capital, New York City Investment Fund and Alexandria Real Estate Equities.

  Next Entries »

to top of page...